News
BrightHeart’s AI-based software for prenatal congenital heart defect (CHD) screening has demonstrated promise in two new studies. The French company’s AI software received 510(k) clearance ...
We may make money when you click on links to our partners. Learn More. The FDA has granted 510(k) clearance to BrightHeart, a Paris-based AI innovator specializing in obstetric and pediatric ...
PARIS--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary ...
BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, announced today the 510(k) clearance for updates to the BrightHeart platform, adds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results